We are a rapidly growing, Boston-based medical technology company using AI to enable clinicians to make informed decisions on cardiovascular care - leading to better patient outcomes, improved quality of care, and reduced healthcare costs. Come work at Elucid and be part of delivering on our mission to prevent heart attacks and strokes!
Are you ready to shape the future of cardiovascular diagnostics? As a Program Manager at Elucid, you'll be at the intersection of innovation and execution. You will orchestrate cardiovascular imaging projects across key stakeholder and engineering teams to deliver innovative solutions on time and within scope in a dynamic startup environment. With your strong technical foundation and experience in successfully delivering complex SaMD products, you'll be a driving force behind our mission to transform cardiovascular care.
The ideal candidate will have:- Bachelor’s degree in engineering, Computer Science, Life Sciences, or a related field.
- 5+ years of experience in agile program management for SaMD products. Cardiovascular imaging program management experience preferred.
- Proven track record of managing complex projects from concept to commercialization.
- In-depth knowledge of regulatory requirements and standards for medical devices, software lifecycle processes and risk management.
- Excellent leadership, communication, and interpersonal skills, with the ability to influence and collaborate effectively with cross-functional teams.
- Strong analytical and problem-solving skills, with a detail-oriented approach.
- Software tools knowledge preferred: Jira, Roadmunk or similar applications, Salesforce.
- This role is based out of our office in Boston, MA. For local candidates, we operate in a hybrid model with regular in-office collaboration. Candidates outside of the Boston area are invited to apply as fully-remote employees.
- Occasional travel may be required.
Similar Jobs
What We Do
Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid equips physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall and estimation of coding and non-coding RNA transcripts (“Virtual Transcriptomics”). This unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs. The Elucid software is available for commercial use in the U.S. and Europe
